0001685428-20-000004.txt : 20200421 0001685428-20-000004.hdr.sgml : 20200421 20200421141331 ACCESSION NUMBER: 0001685428-20-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200421 DATE AS OF CHANGE: 20200421 EFFECTIVENESS DATE: 20200421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LumiraDx Ltd CENTRAL INDEX KEY: 0001685428 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-364337 FILM NUMBER: 20804840 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ BUSINESS PHONE: 011 44 1786 430411 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2AQ D/A 1 primary_doc.xml X0708 D/A LIVE 0001685428 LumiraDx Ltd 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2AQ 011 44 1786 430411 CAYMAN ISLANDS None None Other Exempted company limited by shares true 2016 Ron Zwanziger c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Scott c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director Jerry McAleer c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Director David Walton c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Nigel Lindner c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE1 2AQ Executive Officer Peter Welch c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Veronique Ameye c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Tom Quinlan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Peter Scheu c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Dorian LeBlanc c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Executive Officer Donald Berwick c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Bruce Keogh c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lurene Joseph c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Lu Huang c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Troyen Brennan c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Suresh Vazirani c/o LumiraDx Limited 3 More London Riverside London X0 UNITED KINGDOM SE 1 2AQ Director Other Health Care Decline to Disclose 06b true 0001685428-20-000002 2020-03-28 false true true true false 1000000 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Lincoln MA MASSACHUSETTS 01773 All States false 74000000 52550000 21450000 Amount sold shown in item 13 and number of investors in item 14 includes $22,000,000 from four non-US investors. false 20 900000 true 0 US Boston Capital Corp. receives an administrative fee and a placement fee based on amount sold. A portion of the fee may be paid in convertible notes. 0 false LumiraDx Ltd /s/Dorian LeBlanc Dorian LeBlanc CFO 2020-04-16